Pediatric regime of chemotherapy proves more effective for young adults

Leukemia patients 16 to 39 have higher long-term survival rates, finds Tel Aviv University researcher

2012-06-19

(Press-News.org) Acute lymphoblastic leukemia (ALL), usually found in pediatric patients, is far more rare and deadly in adolescent and adult patients. According to the National Marrow Donor Program, child ALL patients have a higher than 80 percent remission rate, while the recovery rate for adults stands at only 40 percent.

In current practice, pediatric and young adult ALL patients undergo different treatment regimes. Children aged 0-15 years are typically given more aggressive chemotherapy, while young adults, defined as people between 16 and 39 years of age, are treated with a round of chemotherapy followed by a bone marrow transplant. But a new study has revealed that it may be time to rethink this strategy, says Dr. Ron Ram of Tel Aviv University's Sackler Faculty of Medicine and the Davidoff Cancer Center at the Rabin Medical Center.

Dr. Ram and his fellow researchers have determined that a pediatric treatment regime for young adult patients with ALL improves their chance of long-term survival, and decreases the mortality rate itself by 40% — all without the additional complications of a bone marrow transplant. Their findings have been published in the American Journal of Hematology.

Avoiding the transplant list

There are a number of reasons for the differing treatment regimes, including physical stress, psychological preparedness, and prevalence of the disease. Pediatric oncologists, who see dozens of cases of ALL a month, treat their patients with aggressive chemotherapy because there is a consensus that young children can better cope with the treatment — their heart, liver, and lungs are better able to repair themselves after exposure to the toxic cancer-fighting drugs, and they have better psychological support systems to deal with their situation.

Adult oncologists, on the other hand, proceed with more caution, believing that the older body has less ability to heal itself and that adults are not as psychologically well-adapted for the hardships of intensive chemotherapy. In addition, the smaller number of young and mature adult ALL patients means that fewer studies and clinical trials have been done on adolescents and adults with the disease, so less information is available.

For their study, Dr. Ram and his fellow researchers conducted a systematic review of 11 comparative studies comparing the outcomes of 2,489 individuals aged 16-39. They completed an analysis to determine how the young adult regime compared to the pediatric treatment for this age group. They discovered that at three years, mortality was significantly lower when the patient was treated with the pediatric regime than with the adult chemotherapy/transplant combination, with a remission rate closer to that in children. Relapse rates were also significantly lower.

"The long-term survival of these young adults increased significantly when following the pediatric treatment," concludes Dr. Ram. The results disproved the assumption that with the more aggressive chemotherapy, young adult patients would have higher toxicity rates. "There was a worry that the patients might suffer or even die from the toxicity of the treatment, but toxicity rates remained the same. With the pediatric treatment, patients were more frequently in remission and had prolonged survival without bone marrow transplantation — which itself is hard on the body."

More trials needed

Though the comparative studies have pointed researchers in the right direction, Dr. Ram says that this study is limited by a lack of randomized controlled trials, which could give more insight into whether the pediatric regime should be adopted as standard for young adult patients.

Still, the results are persuasive, leading to the conclusion that patients in this age group can be treated as pediatric patients in terms of the level of chemotherapy they can handle. "For a 16-20 year old, I would push them towards a pediatric regime," Dr. Ram says.

###This study was conducted in collaboration with Profs. Ofer Shpilberg and Pia Raanani and Drs. Ofir Wolach, Liat Vidal and Anat Gafter-Gvili.

American Friends of Tel Aviv University (www.aftau.org) supports Israel's leading, most comprehensive and most sought-after center of higher learning. Independently ranked 94th among the world's top universities for the impact of its research, TAU's innovations and discoveries are cited more often by the global scientific community than all but 10 other universities.

Internationally recognized for the scope and groundbreaking nature of its research and scholarship, Tel Aviv University consistently produces work with profound implications for the future.

ELSE PRESS RELEASES FROM THIS DATE:

Key part of plants' rapid response system revealed

2012-06-19

Science has known about plant hormones since Charles Darwin experimented with plant shoots and showed that the shoots bend toward the light as long as their tips, which are secreting a growth hormone, aren't cut off. But it is only recently that scientists have begun to put a molecular face on the biochemical systems that modulate the levels of plant hormones to defend the plant from herbivore or pathogen attack or to allow it to adjust to changes in temperature, precipitation or soil nutrients. Now, a cross-Atlantic collaboration between scientists at Washington University ...

Peaches, plums, nectarines give obesity, diabetes slim chance

2012-06-19

COLLEGE STATION – Peaches, plums and nectarines have bioactive compounds that can potentially fight-off obesity-related diabetes and cardiovascular disease, according to new studies by Texas AgriLife Research. The study, which will be presented at the American Chemical Society in Philadelphia next August, showed that the compounds in stone fruits could be a weapon against "metabolic syndrome," in which obesity and inflammation lead to serious health issues, according to Dr. Luis Cisneros-Zevallos, AgriLife Research food scientist. "In recent years obesity ...

Device implanted in brain has therapeutic potential for Huntington's disease

2012-06-19

Amsterdam, NL, June 18, 2012 – Studies suggest that neurotrophic factors, which play a role in the development and survival of neurons, have significant therapeutic and restorative potential for neurologic diseases such as Huntington's disease. However, clinical applications are limited because these proteins cannot easily cross the blood brain barrier, have a short half-life, and cause serious side effects. Now, a group of scientists has successfully treated neurological symptoms in laboratory rats by implanting a device to deliver a genetically engineered neurotrophic ...

Link between vitamin C and twins can increase seed production in crops

2012-06-19

RIVERSIDE, Calif. — Biochemists at the University of California, Riverside report a new role for vitamin C in plants: promoting the production of twins and even triplets in plant seeds. Daniel R. Gallie, a professor of biochemistry, and Zhong Chen, an associate research biochemist in the Department of Biochemistry, found that increasing the level of dehydroascorbate reductase (DHAR), a naturally occurring enzyme that recycles vitamin C in plants and animals, increases the level of the vitamin and results in the production of twin and triplet seedlings in a single seed. The ...

Research breakthrough: High brain integration underlies winning performances

2012-06-19

Scientists trying to understand why some people excel — whether as world-class athletes, virtuoso musicians, or top CEOs — have discovered that these outstanding performers have unique brain characteristics that make them different from other people. A study published in May in the journal Cognitive Processing found that 20 top-level managers scored higher on three measures — the Brain Integration Scale, Gibbs's Socio-moral Reasoning questionnaire, and an inventory of peak experiences — compared to 20 low-level managers that served as matched controls. This is the fourth ...

This is your brain on no self-control

2012-06-19

New pictures from the University of Iowa show what it looks like when a person runs out of patience and loses self-control. A study by University of Iowa neuroscientist and neuro-marketing expert William Hedgcock confirms previous studies that show self-control is a finite commodity that is depleted by use. Once the pool has dried up, we're less likely to keep our cool the next time we're faced with a situation that requires self-control. But Hedgcock's study is the first to actually show it happening in the brain using fMRI images that scan people as they perform self-control ...

Million year old groundwater in Maryland water supply

2012-06-19

A portion of the groundwater in the upper Patapsco aquifer underlying Maryland is over a million years old. A new study suggests that this ancient groundwater, a vital source of freshwater supplies for the region east of Washington, D.C. and Baltimore, was recharged over periods of time much greater than human timescales. "Understanding the average age of groundwater allows scientists to estimate at what rate water is re-entering the aquifer to replace the water we are currently extracting for human use," explained USGS Director Marcia McNutt. "This is the first step ...

Anti-cocaine vaccine described in Human Gene Therapy Journal

2012-06-19

New Rochelle, NY, June 18, 2012—A single-dose vaccine capable of providing immunity against the effects of cocaine offers a novel and groundbreaking strategy for treating cocaine addiction is described in an article published Instant Online in Human Gene Therapy, a peer-reviewed journal from Mary Ann Liebert, Inc. (http://www.liebertpub.com) The article is available free online at the Human Gene Therapy website (http://www.liebertpub.com/hum). "This is a very novel approach for addressing the huge medical problem of cocaine addiction," says James M. Wilson, MD, PhD, Editor-in-Chief, ...

Doctors cite concern for patients, colleagues top motives for working sick

2012-06-19

An unwavering work ethic is a hallmark of many health professionals. But a new survey finds that when a doctor is sick, staunch dedication can have unintended consequences. A poll of 150 attendees of an American College of Physicians meeting in 2010 revealed that more than half of resident physicians had worked with flu-like symptoms at least once in the last year. One in six reported working sick on three or more occasions during the year, according to the survey conducted by researchers at the University of Chicago Medicine and Massachusetts General Hospital. Notably, ...

Canadian teen moms run higher risk of abuse, depression than older mothers

2012-06-19

(Edmonton) Teen mothers are far more likely to suffer abuse and postpartum depression than older moms, according to a study of Canadian women's maternity experiences by a University of Alberta researcher. Dawn Kingston, an assistant professor in the Faculty of Nursing, analyzed data from the Maternity Experiences Survey, which asked more than 6,400 new mothers about their experiences with stress, violence, pre- and postnatal care, breastfeeding and risky behaviour like smoking and drug use before, during and after pregnancy. Kingston said the survey offers the first ...

Pediatric regime of chemotherapy proves more effective for young adults

ELSE PRESS RELEASES FROM THIS DATE:

LAST 30 PRESS RELEASES: